Published September 5, 2012 This content is archived.
Sophie Belin, PhD, a postdoctoral research scientist in biochemistry, has received the 2012 Peripheral Nerve Society (PNS) Neuropathy Fellowship.
She was selected for the competitive $40,000 grant to investigate a pharmacological approach to treat hereditary neuropathy of the Charcot-Marie-Tooth (CMT) disease type.
Belin will work on the project with her mentor, Lawrence Wrabetz, MD, professor of neurology and biochemistry and director of the Hunter James Kelly Research Institute.
They will perform a preclinical trial of a known drug for arthritis in an authentic transgenic mouse model of CMT, using behavioral, behavioral, electrophysiological, histological and biochemical methods to measure effects on myelination.